<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04405336</url>
  </required_header>
  <id_info>
    <org_study_id>tab block</org_study_id>
    <nct_id>NCT04405336</nct_id>
  </id_info>
  <brief_title>Tab Block and Patient Controlled Analgesia in CS</brief_title>
  <official_title>Effect of Tab Block and Patient Controlled Analgesia in Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aljazeera Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aljazeera Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      cesarean section rate become increasing nowadays
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      indication of cesarean section are different from case to case and the use of pain
      controlling agents is very important to relieve post operative pain
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 28, 2020</start_date>
  <completion_date type="Anticipated">September 25, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of women who will feel less pain post CS</measure>
    <time_frame>2 days</time_frame>
    <description>the degree of pain that will be felt post CS</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>giving tab block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>giving patients tab block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>giving PCA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Giving PCA to patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients who will not receive PCA or tab block</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No tab block or PCA</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tab block</intervention_name>
    <description>injection of tab block to women who are doing cs</description>
    <arm_group_label>giving tab block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PCA</intervention_name>
    <description>giving women PCA</description>
    <arm_group_label>giving PCA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>women who will not receive tab block or PCA</intervention_name>
    <description>no tab block or PCA will be given</description>
    <arm_group_label>giving PCA</arm_group_label>
    <arm_group_label>giving tab block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women coming for an elective CS

        Exclusion Criteria:

          -  women who has a n emergency CS or complicated normal deivery needs urgent CS
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women undergoing CS</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Alalfy, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Algezeera hospitaland National Research Centre ,Egypt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud Alalfy, PhD</last_name>
    <phone>01002611058</phone>
    <email>mahmoudalalfy@ymail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aljazeera( Al Gazeera) hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 23, 2020</study_first_submitted>
  <study_first_submitted_qc>May 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2020</study_first_posted>
  <last_update_submitted>May 23, 2020</last_update_submitted>
  <last_update_submitted_qc>May 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

